ArticleHeliyon2022
Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent.
Orkhan Mammadov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it